Temperature Tolerance Did Not Remove Cannabinoid-Related Prolongation of Pentobarbital Sleep in Mice
A 1982 mouse study found that tolerance to cannabinoid-induced cooling developed differently from tolerance to prolonged pentobarbital sleep. A normal temperature response did not establish disappearance of the drug-combination effect.
Several delta-8-related compounds were compared
Mice received repeated intravenous delta-8 THC or its 11-hydroxy and 11-oxo derivatives. Investigators assessed hypothermia and prolongation of sleep induced by pentobarbital. These are different pharmacological endpoints, and the latter involves another active drug.
The later comparison exposed incomplete adaptation
Both effects became tolerant, but by different degrees. After the eighth cannabinoid injection, sleep durations remained significantly longer than control durations even when hypothermia was no longer induced. The temperature endpoint therefore could not serve as a complete indicator of functional recovery.
The experiment did not identify a safe sedative combination
The abstract does not resolve whether altered drug disposition, central sensitivity or another mechanism explained persistent sleep prolongation. It also does not establish natural sleep quality or a therapeutic sleep benefit. Drug-induced sleeping time is a laboratory measure with its own limitations.
The finding is relevant to interpreting claims that tolerance eliminates all cannabinoid effects. It demonstrates an endpoint exception in injected mice, not a human interaction magnitude or dosing recommendation. Parent cannabinoids and metabolites should also remain separate rather than being relabeled collectively as ordinary marijuana.
Related: interpreting cannabis tolerance claims.
Research cited
Watanabe K; Narimatsu S; Yamamoto I; Yoshimura H. Difference in tolerance development of hypothermia and pentobarbital-induced sleep prolongating effect of 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol in mice. European journal of pharmacology (1982). doi:10.1016/0014-2999(82)90535-0. Findings discussed from the study abstract.
